Feb 1, 2023 | Drugs, Issue of the Month
Process and Manufacturing Optimization to Minimize Inflation Impact on the Pharmaceutical Industry By Ibrahim Khattab, EAS Independent Consultant Rising inflation rates, the Russian invasion of Ukraine and the associated rise in energy prices, and the numerous...
Jan 30, 2023 | Drug and Device Corner, Drugs, Medical Devices
On 29 December 2022, the U.S. President signed H.R 2617 – the Consolidated Appropriations Act, 2023 into law which includes the Food and Drug Omnibus Reform Act. Of particular interest in this legislation for EAS drug and device clients, are the following: The...
Jan 4, 2023 | Drugs, FDA and USDA Regulatory Update
What You Need to Know The U.S. Food and Drug Administration has issued a final guidance on Homeopathic Drug Products describing the agency’s approach to prioritizing regulatory actions for homeopathic products posing the greatest risk to patients. The agency...
Dec 22, 2022 | Drug and Device Corner, Drugs, Medical Devices
We wish you all a very happy holiday season and prosperous new year. Reminder of the deadline of 31 December 2022 for the establishment registration and product listing renewal period. For those that have not already submitted their CARES Act reporting for FY2020 and...
Nov 22, 2022 | Drug and Device Corner, Drugs, Medical Devices
Reminder that December is the deadline for the establishment registration and product listing renewal period. Kindly note the FDA has tightened up their validation process for drug listings. Although repack / relabeled listings have been submitted in the past without...
